| Description |
xvii, 240, 13 unnumbered pages : illustrations (some colour), tables ; 30 cm |
| Note |
Submitted in fulfilment of the requirement for the degree of Doctor of Philosophy (PhD). Cancer Research UK, Beatson Institute, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, February 2019. |
|
Includes published article from peer reviewed journal. |
| Thesis |
Ph.D. University of Glasgow 2019 Institute of Cancer Sciences, Beatson Institute of Cancer Research. |
| Bibliography |
Includes bibliographical references (pages 203-239). |
| Access |
Due to embargo issues this thesis is not available for consultation without the author's written permission until 27 February 2022. |
| Note |
Electronic version deposited with Enlighten : Theses: http://theses.gla.ac.uk/41042/ but unavailable for viewing due to copyright issues. Edited version (3rd party copyright removed) will be made available post embargo. |
| Library Class |
Thesis TA5383
|
| Subject |
p53 antioncogene -- Theses PhD.
|
|
Ubiquitin -- Theses PhD.
|
|
Cancer -- Molecular aspects -- Theses PhD.
|
|
Cancer -- Genetic aspects -- Theses PhD.
|
| Other Author |
University of Glasgow, degree granting institution.
|
|
